| Chronic Kidney Disease and Diabetes | Lifetime | 82 | NL 6 | 99.40 |
| Dialysis and Renal Disease Management | Lifetime | 114 | NL 6 | 99.32 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 187 | NL 5 | 99.03 |
| Renal and Vascular Pathologies | Lifetime | 167 | NL 7 | 98.72 |
| Folate and B Vitamins Research | Lifetime | 187 | NL 10 | 97.95 |
| Liver Disease Diagnosis and Treatment | Lifetime | 889 | NL 13 | 98.92 |
| Electrolyte and hormonal disorders | Lifetime | 163 | NL 7 | 98.11 |
| Blood Pressure and Hypertension Studies | Lifetime | 440 | NL 16 | 98.71 |
| Diet and metabolism studies | Lifetime | 864 | NL 27 | 98.52 |
| Parathyroid Disorders and Treatments | Lifetime | 232 | NL 6 | 98.36 |
| Sodium Intake and Health | Lifetime | 108 | NL 4 | 98.12 |
| Nutrition and Health in Aging | Lifetime | 625 | NL 30 | 97.83 |
| Nutritional Studies and Diet | Lifetime | 545 | NL 22 | 98.21 |
| Renal function and acid-base balance | Lifetime | 235 | NL 9 | 97.37 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 592 | NL 27 | 98.12 |
| Lipoproteins and Cardiovascular Health | Lifetime | 767 | NL 28 | 97.03 |
| Potassium and Related Disorders | Lifetime | 166 | NL 10 | 96.75 |
| Advanced Glycation End Products research | Lifetime | 398 | NL 9 | 95.17 |
| Magnesium in Health and Disease | Lifetime | 180 | NL 7 | 95.09 |
| Alcohol Consumption and Health Effects | Lifetime | 989 | NL 11 | 94.26 |
| Erythropoietin and Anemia Treatment | Lifetime | 421 | NL 13 | 94.11 |
| Neurological Complications and Syndromes | Lifetime | 449 | NL 14 | 93.35 |
| Apelin-related biomedical research | Lifetime | 367 | NL 7 | 91.43 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 894 | NL 6 | 92.58 |
| Vitamin K Research Studies | Lifetime | 499 | NL 30 | 88.65 |
| Alcoholism and Thiamine Deficiency | Lifetime | 674 | NL 17 | 87.83 |
| Biomarkers in Disease Mechanisms | Lifetime | 824 | NL 16 | 81.04 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 307 | NL 7 | 83.32 |
| Cynara cardunculus studies | Lifetime | 924 | NL 15 | 52.50 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 12 | NL 1 | 99.21 |
| Dialysis and Renal Disease Management | 2021-2025 | 52 | NL 5 | 98.63 |
| Nutrition and Health in Aging | 2021-2025 | 183 | NL 5 | 97.59 |
| Parathyroid Disorders and Treatments | 2021-2025 | 80 | NL 6 | 96.48 |
| Renal and Vascular Pathologies | 2021-2025 | 77 | NL 3 | 96.00 |
| Nutritional Studies and Diet | 2021-2025 | 270 | NL 8 | 96.29 |
| Diet and metabolism studies | 2021-2025 | 475 | NL 12 | 95.42 |
| Metabolism and Genetic Disorders | 2021-2025 | 151 | NL 11 | 93.21 |
| Neurological Complications and Syndromes | 2021-2025 | 36 | NL 2 | 94.03 |
| Folate and B Vitamins Research | 2021-2025 | 156 | NL 6 | 88.04 |
| Liver Disease and Transplantation | 2021-2025 | 705 | NL 11 | 93.75 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 383 | NL 11 | 91.72 |
| Fibroblast Growth Factor Research | 2021-2025 | 95 | NL 1 | 87.97 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 276 | NL 10 | 91.18 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 658 | NL 23 | 89.11 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 738 | NL 17 | 86.73 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 985 | NL 35 | 88.50 |
| Iron Metabolism and Disorders | 2021-2025 | 538 | NL 8 | 86.30 |
| Renal function and acid-base balance | 2021-2025 | 137 | NL 6 | 81.94 |
| Diet, Metabolism, and Disease | 2021-2025 | 745 | NL 11 | 84.05 |
| Organ Donation and Transplantation | 2021-2025 | 533 | NL 34 | 84.60 |
| Trace Elements in Health | 2021-2025 | 571 | NL 3 | 80.15 |
| Muscle metabolism and nutrition | 2021-2025 | 713 | NL 28 | 82.33 |
| Clinical Nutrition and Gastroenterology | 2021-2025 | 519 | NL 24 | 79.67 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 244 | NL 7 | 79.57 |
| Pregnancy and Medication Impact | 2021-2025 | 939 | NL 48 | 71.49 |
| Vitamin K Research Studies | 2021-2025 | 126 | NL 11 | 70.73 |
| Magnesium in Health and Disease | 2021-2025 | 173 | NL 11 | 70.42 |
| Body Composition Measurement Techniques | 2021-2025 | 996 | NL 16 | 70.86 |
| Electrolyte and hormonal disorders | 2021-2025 | 824 | NL 41 | 62.25 |
| Sodium Intake and Health | 2021-2025 | 844 | NL 14 | 60.10 |
| Potassium and Related Disorders | 2021-2025 | 730 | NL 26 | 59.93 |
| Kruppel-like factors research | 2021-2025 | 617 | NL 5 | 57.09 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 675 | NL 29 | 53.57 |
| Neurological and metabolic disorders | 2021-2025 | 686 | NL 21 | 43.02 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 757 | NL 8 | 42.30 |
| Redox biology and oxidative stress | 2021-2025 | 842 | NL 3 | 30.34 |